| Literature DB >> 21572833 |
Beatriz Pérez-Cadahía1, Josefina Méndez, Eduardo Pásaro, Anunciación Lafuente, Teresa Cabaleiro, Blanca Laffon.
Abstract
Since 1960, about 400 tankers spilled more than 377765 tons of oil, with the Prestige accident (Galician coast, NW Spain, November 2002) the most recent. Taking into account the consistent large number of individuals exposed to oil that exists all over the world, it seems surprising the absence in the literature of studies focused on the chronic effects of this exposure on human health. In this work we evaluated the level of DNA damage by means of comet assay, and the potential endocrine alterations (prolactin and cortisol) caused by Prestige oil exposure in a population of 180 individuals, classified in 3 groups according to the tasks performed, and 60 controls. Heavy metals in blood were determined as exposure biomarkers, obtaining significant increases of aluminum, nickel and lead in the exposed groups as compared to controls. Higher levels of genetic damage and endocrine alterations were also observed in the exposed population. DNA damage levels were influenced by age, sex, and the use of protective clothes, and prolactin concentrations by the last two factors. Surprisingly, the use of mask did not seem to protect individuals from genetic or endocrine alterations. Moreover, polymorphisms in genes encoding for the main enzymes involved in the metabolism of oil components were analyzed as susceptibility biomarkers. CYP1A1-3'UTR and EPHX1 codons 113 and 139 variant alleles were related to higher damage levels, while lower DNA damage was observed in GSTM1 and GSTT1 null individuals.Entities:
Keywords: Prestige oil; comet assay; cortisol; metabolic polymorphisms; prolactin
Year: 2008 PMID: 21572833 PMCID: PMC3091333 DOI: 10.4137/ehi.s954
Source DB: PubMed Journal: Environ Health Insights ISSN: 1178-6302
Figure 1.Heavy metal blood concentrations (mean ± SE) in the studied populations: aluminum A), cadmium B), nickel C), lead D) and zinc E). *P < 0.05; **P < 0.01, significant difference with regard to controls. Results adjusted by sex, age and tobacco smoking.
Figure 2.Effect of exposure on DNA damage expressed as %TDNA A), prolactin B) and cortisol C) plasmatic levels (mean ± SE). **P < 0.01, significant difference with regard to controls. Results adjusted by sex, age and smoking habits.
Influence of sex, age, smoking habits and the use of protective clothes and mask on DNA damage and endocrine parameters. Models adjusting by exposure. CI: confidence interval, R2: correlation coefficient.
| 1. Comet assay (%TDNA) | |||||
| Males vs. females | 0.015 | 0.009 to 0.022 | 0.000 | 0.140 | 0.000 |
| Age (years) | 0.002 | 0.002 to 0.002 | 0.000 | 0.145 | 0.000 |
| Non-smokers vs. smokers | −0.007 | 0.013 to 0.000 | 0.064 | 0.139 | 0.000 |
| No clothes vs. clothes | 0.020 | 0.007 to 0.033 | 0.003 | 0.119 | 0.000 |
| No mask vs. mask | 0.003 | − 0.008 to 0.014 | 0.621 | 0.118 | 0.000 |
| 2. Prolactin (ng/ml) | |||||
| Males vs. females | −2.386 | −4.346 to −0.427 | 0.017 | 0.041 | 0.064 |
| Age (years) | −0.048 | −0.170 to 0.074 | 0.438 | 0.015 | 0.533 |
| Non-smokers vs. smokers | −0.722 | −2.760 to 1.316 | 0.486 | 0.017 | 0.455 |
| No clothes vs. clothes | 4.117 | 0.022 to 8.212 | 0.049 | 0.028 | 0.226 |
| No mask vs. mask | 0.305 | −3.907 to 4.516 | 0.887 | 0.003 | 0.928 |
| 3. Cortisol (ng/ml) | |||||
| Males vs. females | −0.590 | −2.215 to 1.036 | 0.475 | 0.108 | 0.000 |
| Age (years) | 0.044 | −0.056 to 0.144 | 0.389 | 0.113 | 0.000 |
| Non-smokers vs. smokers | −1.074 | −2.747 to 0.600 | 0.207 | 0.112 | 0.000 |
| No clothes vs. clothes | −1.597 | −4.430 to 1.235 | 0.267 | 0.125 | 0.000 |
| No mask vs. mask | 0.858 | −1.940 to 3.656 | 0.546 | 0.102 | 0.000 |
Models excluding control individuals.
Influence of metabolic polymorphisms on %TDNA (mean ± SE). N is indicated between brackets.
| CYP1A1*1A/*1A | 0.079 ± 0.002 | 0.176 ± 0.003 | 0.307 ± 0.007 | 0.104 ± 0.002 | 0.122 ± 0.003 |
| CYP1A1*1A/*2A | 0.089 ± 0.004 | 0.180 ± 0.005 | 0.378 ± 0.016 | 0.099 ± 0.004 | 0.117 ± 0.005 |
| CYP1A1*2A/*2A | 0.657 ± 0.072 | 0.657 ± 0.072 | |||
| EPHX1–113Tyr/Tyr | 0.075 ± 0.002 | 0.183 ± 0.003 | 0.352 ± 0.009 | 0.102 ± 0.003 | 0.112 ± 0.003 |
| EPHX1–113Tyr/His + His/His | 0.086 ± 0.003 | 0.174 ± 0.003 | 0.292 ± 0.008 | 0.103 ± 0.003 | 0.128 ± 0.003 |
| EPHX1–139His/His | 0.083 ± 0.0.002 | 0.179 ±0.003 | 0.316 ± 0.007 | 0.098 ± 0.003 | 0.121 ± 0.003 |
| EPHX1–139His/Arg + Arg/Arg | 0.067 ± 0.003 | 0.177 ± 0.004 | 0.343 ± 0.012 | 0.110 ± 0.004 | 0.121 ± 0.004 |
| GSTP1Ile/Ile | 0.085 ± 0.002 | 0.176 ± 0.003 | 0.355 ± 0.010 | 0.110 ± 0.003 | 0.109 ± 0.003 |
| GSTP1Ile/Val + Val/Val | 0.079 ± 0.002 | 0.180 ± 0.003 | 0.296 ± 0.008 | 0.094 ± 0.003 | 0.138 ± 0.004 |
| GSTM1 positive | 0.081 ± 0.002 | 0.203 ± 0.003 | 0.329 ± 0.007 | 0.114 ± 0.003 | 0.118 ± 0.004 |
| GSTM1 null | 0.076 ± 0.002 | 0.151 ± 0.003 | 0.312 ± 0.011 | 0.093 ± 0.003 | 0.123 ± 0.003 |
| GSTT1 positive | 0.078 ± 0.002 | 0.178 ±0.002 | 0.329 ± 0.001 | 0.114 ± 0.001 | 0.124 ± 0.003 |
| GSTT1 null | 0.112 ± 0.010 | 0.181 ± 0.007 | 0.355 ± 0.018 | 0.086 ± 0.007 | 0.104 ± 0.005 |
P < 0.01;
P < 0.05, significant difference regarding to the wild type homozygote or positive group.